Clinuvel Pharmaceuticals Ltd has released a press release.
Media Release - CLINUVEL to Trial Innovative Drug in Stroke
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- Australian TGA approves SCENESSE
- Trading Halt
- Media Release - First patient dosed in SCENESSE DNA Repair
- CLINUVEL progresses innovative DNA Repair Program
- Corporate Presentation - 2020 Full Year Results
Later from Clinuvel Pharmaceuticals
- CLINUVEL Strategic Update - Extended
- Appendix 4D Half Yearly Report
- Media Release - CLINUVEL expands DNA Repair Program
- Appendix 4C - quarterly
- Appendix 4E and Preliminary Financial Report
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals